Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate-specific antigen era

Journal of the National Cancer Institute

Volumn 106, Issue 2, 2014, Pages

  Zu, Ke ^a   Mucci, Lorelei ^a,b   Rosner, Bernard A ^a,b   Clinton, Steven K ^c   Loda, Massimo ^d   Stampfer, Meir J ^a,b   Giovannucci, Edward ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAROTENOID; LYCOPENE; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AGED; APOPTOSIS; ARTICLE; BLOOD; CELL PROLIFERATION; DISEASE COURSE; FEEDING BEHAVIOR; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INCIDENCE; MALE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTATE TUMOR; PROSTATECTOMY; QUESTIONNAIRE; RISK; TISSUE MICROARRAY; UNITED STATES; VASCULARIZATION;

AGED; ANTICARCINOGENIC AGENTS; APOPTOSIS; CAROTENOIDS; CELL PROLIFERATION; DISEASE PROGRESSION; FOOD HABITS; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUESTIONNAIRES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 84893830711     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt430     Document Type: Article

References (48)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.
2. Giovannucci E. Does prostate-specific antigen screening influence the results of studies of tomatoes, lycopene, and prostate cancer risk? J Natl Cancer Inst. 2007;99(14):1060-1062.
3. Giovannucci E, Liu Y, Platz EA, et al. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121(7):1571-1578.
4. Ilic D, Forbes KM, Hassed C. Lycopene for the prevention of prostate cancer. Cochrane Database Syst Rev. 2011;2011(11): CD008007.
5. Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 1995;87(23):1767-1776.
6. Cerhan JR, Cantor KP, Williamson K, et al. Cancer mortality among Iowa farmers: recent results, time trends, and lifestyle factors (United States). Cancer Causes Control. 1998;9(3):311-319.
7. Mills PK, Beeson WL, Phillips RL, et al. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer. 1989;64(3):598-604.
8. Kirsh VA, Mayne ST, Peters U, et al. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(1):92-98.
9. Kristal AR, Arnold KB, Neuhouser ML, et al. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol. 2010;172(5):566-577.
10. Giovannucci E, Rimm EB, Liu Y, et al. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst. 2002;94(5):391-398.
11. Le Marchand L, Hankin JH, Kolonel LN, et al. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary beta-carotene. Am J Epidemiol. 1991;133(3):215-219.
12. Key TJ, Silcocks PB, Davey GK, et al. A case-control study of diet and prostate cancer. Br J Cancer. 1997;76(5):678-687.
13. Meyer F, Bairati I, Fradet Y, et al. Dietary energy and nutrients in relation to preclinical prostate cancer. Nutr Cancer. 1997;29(2):120-126.
14. Deneo-Pellegrini H, De Stefani E, Ronco A, et al. Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer. 1999;80(3-4):591-597.
15. Jain MG, Hislop GT, Howe GR, et al. Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr Cancer. 1999;34(2):173-184.
16. Vogt TM, Mayne ST, Graubard BI, et al. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US blacks and whites. Am J Epidemiol. 2002;155(11):1023-1032.
17. Bosetti C, Talamini R, Montella M, et al. Retinol, carotenoids and the risk of prostate cancer: a case-control study from Italy. Int J Cancer. 2004;112(4):689-692.
18. Key TJ, Appleby PN, Allen NE, et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr. 2007;86(3):672-681.
19. Pourmand G, Salem S, Mehrsai A, et al. The risk factors of prostate cancer: a multicentric case-control study in Iran. Asian Pac J Cancer Prev. 2007;8(3):422-428.
20. Kristal AR, Till C, Platz EA, et al. Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2011;20(4):638-646.
21. Schuurman AG, Goldbohm RA, Dorant E, et al. Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands. Cancer Epidemiol Biomarkers Prev. 1998;7(8):673-680.
22. Peters U, Leitzmann MF, Chatterjee N, et al. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2007;16(5):962-968.
23. Beilby J, Ambrosini GL, Rossi E, et al. Serum levels of folate, lycopene, beta-carotene, retinol and vitamin E and prostate cancer risk. Eur J Clin Nutr. 2010;64(10):1235-1238.
24. Huang HY, Alberg AJ, Norkus EP, et al. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol. 2003;157(4):335-344.
25. Jian L, Lee AH, Binns CW. Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr. 2007;16 (Suppl 1):453-457.
26. Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a metaanalysis of observational studies. Cancer Epidemiol Biomarkers Prev. 2004;13(3):340-345.
27. Wu K, Erdman JW Jr, Schwartz SJ, et al. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2004;13(2):260-269.
28. Jian L, Du CJ, Lee AH, et al. Do dietary lycopene and other carotenoids protect against prostate cancer? Int J Cancer. 2005;113(6):1010-1014.
29. Karppi J, Kurl S, Nurmi T, et al. Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study. Ann Epidemiol. 2009;19(7):512-518.
30. Chug-Ahuja JK, Holden JM, Forman MR, et al. The development and application of a carotenoid database for fruits, vegetables, and selected multicomponent foods. J Am Diet Assoc. 1993;93(3):318-323.
31. Mangels AR, Holden JM, Beecher GR, et al. Carotenoid content of fruits and vegetables: an evaluation of analytic data. J Am Diet Assoc. 1993;93(3):284-296.
32. Tonucci LH, Holden JM, Beecher GR, Khachik F, Davis CS, Mulokozi G. Carotenoid content of thermally processed tomato-based food products. J Agric Food Chem. 1995;43(3):579-586.
33. Greene FL, American Joint Committee on Cancer, and American Cancer Society. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
34. Mucci LA, Powolny A, Giovannucci E, et al. Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J Clin Oncol. 2009;27(33):5627-5633.
35. Pettersson A, Graff RE, Bauer SR, et al. The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012;21(9):1497-1509.
36. Dhillon PK, Barry M, Stampfer MJ, et al. Aberrant cytoplasmic expression of p63 and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev. 2009;18(2):595-600.
37. Zu K, Martin NE, Fiorentino M, et al. Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev. 2013;22(11):1984-1993.
38. Willett W. Nutritional Epidemiology. 2nd ed. New York: Oxford University Press; 1998.
39. Kavanaugh CJ, Trumbo PR, Ellwood KC. The US Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst. 2007;99(14):1074-1085.
40. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: American Institute for Cancer Research; 2007.
41. Giovannucci E. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med (Maywood). 2002;227(10):852-859.
42. Unlu NZ, Bohn T, Clinton SK, et al. Carotenoid absorption from salad and salsa by humans is enhanced by the addition of avocado or avocado oil. J Nutr. 2005;135(3):431-436.
43. Unlu NZ, Bohn T, Francis DM, et al. Lycopene from heat-induced cisisomerrich tomato sauce is more bioavailable than from all-trans-rich tomato sauce in human subjects. Br J Nutr. 2007;98(1):140-146.
44. Giovannucci E. Commentary: Serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial. Cancer Causes Control. 2011;22(7):1055-1059.
45. Yang CM, Yen YT, Huang CS, et al. Growth inhibitory efficacy of lycopene and beta-carotene against androgen-independent prostate tumor cells xenografted in nude mice. Mol Nutr Food Res. 2011;55(4):606-612.
46. Elgass S, Cooper A, Chopra M. Lycopene inhibits angiogenesis in human umbilical vein endothelial cells and rat aortic rings. Br J Nutr. 2012;108(3):431-439.
47. Huang CS, Chuang CH, Lo TF, et al. Anti-angiogenic effects of lycopene through immunomodualtion of cytokine secretion in human peripheral blood mononuclear cells. J Nutr Biochem. 2012;24(2):428-434.
48. Chen ML, Lin YH, Yang CM, et al. Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways. Mol Nutr Food Res. 2012;56(6):889-899.